Search Results for "Advanced glycation end-product" - 59 interactions found in 9 entries.

Entry-ID
Interactor1 (Subject) Interaction type Interactor2 (Object) additional information
PubMed-ID
Diseases
2,083
16817 Reactive oxygen species increases_quantity of Advanced glycation end-product
10783895 Diabetes mellitus, type II
Insulin resistance
2,088
16827 hyperglycemia increases_quantity of Advanced glycation end-product
16837 response to oxidative stress increases_quantity of Advanced glycation end-product
16838 Advanced glycation end-product affects_activity of regulation of vascular permeability
16839 Advanced glycation end-product increases_expression of VCAM1
16840 Advanced glycation end-product affects_quantity of NO
16841 Advanced glycation end-product affects_activity of coagulation
16842 Advanced glycation end-product increases_expression of F3
16844 Advanced glycation end-product interacts (colocalizes) with AGER
16852 Diabetes mellitus, type II increases_quantity of Advanced glycation end-product
10082470 Diabetes mellitus, type II
Insulin resistance
3,699
35888 hyperglycemia increases_quantity of Advanced glycation end-product
22329649 Alzheimer disease
3,761
36753 Advanced glycation end-product interacts (colocalizes) with amyloid beta deposits in Alzheimer disease
36756 Advanced glycation end-product increases_expression of TNF
36757 Advanced glycation end-product increases_expression of Matrix metallopeptidase
36758 Advanced glycation end-product increases_expression of NOS2
36759 Advanced glycation end-product increases_quantity of amyloid beta deposits
36761 Advanced glycation end-product decreases_activity of learning or memory
36762 Advanced glycation end-product increases_activity of neuron death in an Abeta-rich environment; via neurotoxicity.
22970774 Alzheimer disease
3,792
37454 Advanced glycation end-product is localized in amyloid beta deposits in AD patients
37455 Advanced glycation end-product is localized in neurofibrillary tangles in AD patients
37456 response to oxidative stress increases_activity of Advanced glycation end-product
37457 Advanced glycation end-product increases_activity of response to oxidative stress
37471 Iron increases_quantity of Advanced glycation end-product
37472 Advanced glycation end-product increases_activity of amyloidosis
37473 Copper increases_quantity of Advanced glycation end-product
37474 Advanced glycation end-product increases_activity of abnormal blood vessel morphology
37475 Advanced glycation end-product is localized in pyramidal neuron
37476 Advanced glycation end-product interacts (colocalizes) with astrocyte in AD brain; (with glial fibrillary acidic protein-positive astrocytes)
37482 Advanced glycation end-product cooccurs with MAPT-hyperphos
37484 Advanced glycation end-product interacts (colocalizes) with neurofibrillary tangles
37510 Advanced glycation end-product increases_quantity of Amyloid beta peptide (oligomer) or high molecular weight forms by decreasing Abeta monomeric
37512 Advanced glycation end-product decreases_quantity of Amyloid beta peptide (monomer) by conversion of Abeta from monomeric to oligomeric or high molecular weight forms
37646 Advanced glycation end-product increases_quantity of Reactive oxygen species in both microglial (CHME-5) and astroglial cells (U373MG)
37647 Advanced glycation end-product increases_activity of apoptotic process if AGEs are highly modified
37648 Retinoic acid increases_activity of Advanced glycation end-product through anion superoxide and peroxide generation in cells
37649 Advanced glycation end-product increases_quantity of Glutathione
37653 Advanced glycation end-product increases_quantity of Lactate
37671 NF-kappaB complex affects_activity of Advanced glycation end-product AGEs can induce the expression of proinflammatory cytokines through nuclear factor KB (NF-KB) dependent pathways
37672 Advanced glycation end-product increases_expression of Proinflammatory cytokine through nuclear factor KB (NF-KB) dependent pathways
37681 Advanced glycation end-product NOT affects_quantity of IL12A-IL12B complex BSA (bovine serum albumin) -AGE was used
37682 Advanced glycation end-product NOT affects_expression of IFNG BSA (bovine serum albumin) -AGE was used
37683 Advanced glycation end-product NOT affects_expression of IL10 BSA (bovine serum albumin) -AGE was used
37734 Advanced glycation end-product increases_activity of AGER through the transcription factors NF-kappaB and Sp-1, causing enhanced AGE-RAGE interactions
37749 Advanced glycation end-product increases_activity of TNF through the transcription factors NF-kappaB and Sp-1, causing enhanced AGE-RAGE interactions
37808 Advanced glycation end-product affects_activity of microglia
37931 Advanced glycation end-product is localized in astrocyte in Alzheimer disease in form of granules
38072 Aminoguanidine decreases_activity of Advanced glycation end-product
38075 Tenilsetam decreases_activity of Advanced glycation end-product
19464758 Alzheimer disease
6,438
60781 Streptozocin-induced diabetes increases_quantity of Advanced glycation end-product in lens
60787 Glycine decreases_quantity of Advanced glycation end-product in lens
60793 Glycine decreases_quantity of Advanced glycation end-product in blood serum
22355255 Diabetes mellitus, type II
Diabetes mellitus, type I
Insulin resistance
6,456
61307 Advanced glycation end-product increases_activity of response to oxidative stress
61308 Advanced glycation end-product increases_activity of inflammatory response
61309 Metformin decreases_quantity of Advanced glycation end-product
22117616 Diabetes mellitus, type II
Cancer
Insulin resistance
6,520
62008 Advanced glycation end-product increases_expression of OLR1 in aortic endothelial cells
62010 Advanced glycation end-product increases_expression of AGER in aortic endothelial cells
17292717 Diabetes mellitus, type II
Insulin resistance
Cardiomyopathy, diabetic
6,747
65373 Methylglyoxal increases_quantity of Advanced glycation end-product
65374 hyperglycemia increases_quantity of Advanced glycation end-product
65635 increased free fatty acid level increases_activity of Advanced glycation end-product in arterial endothelial cells
27230643 Diabetes mellitus, type II
Insulin resistance
Cardiomyopathy, diabetic
-->